Pulmonology
UNC Pediatric Pulmonology provides state of the art diagnosis and treatment of lung disease in children, cutting edge research into many aspects of pulmonary disease, and one of the discipline’s leading fellowship training programs. Our goal is to improve the health and wellbeing of children living with conditions such as aerodigestive disorders, asthma, bronchopulmonary dysplasia (BPD), cystic fibrosis (CF), neuromuscular disorders, primary ciliary dyskinesia (PCD), rare or genetic lung diseases, and others. Our team provides care to children all across North Carolina as well as neighboring states and across the globe.
PULMONOLOGY NEWS
-
Davis Receives 2024 Elizabeth A. Rich, MD Award
Stephanie D. Davis, MD, Chair and Edward C. Curnen, Jr. Distinguished Professor of Pediatrics has been selected by the American Thoracic Society (ATS) as the 2024 recipient of the Elizabeth A. Rich, MD Award.
-
UNC CF Team Featured in January CFF Network News
The UNC Pediatrics CF team was featured in the January edition of the CFF Network News. Written by Mary Beth Prieur, PhD, the article addresses the increasing importance of mental health among the CF community.
-
Celebrating Magee Leigh: Retirement and Lectureship
Dr. Margaret “Magee” Leigh has served as a faculty member in the Department of Pediatrics and the Pulmonary Division for over 40 years. Throughout her tenure, she has provided care for children with chronic lung diseases, taught medical students, residents and pulmonary fellows and engaged in research of chronic lung diseases with a specific focus on cystic fibrosis and primary ciliary dyskinesia. With her recent retirement, we wish to honor Dr. Leigh’s legacy with a lectureship in her honor. The lectureship will help us bring in experts from around the world to help train and inform the next generation of learners.
-
Researchers Release Results from Clinical Trial for Treatment of Primary Ciliary Dyskinesia
A phase 2 study, led by Thomas W. Ferkol, MD, at the UNC School of Medicine, demonstrates safety and efficacy of idrevloride with hypertonic saline for treatment of primary ciliary dyskinesia, a rare genetic disorder that can lead to permanent lung damage.